pyrroles has been researched along with Toxoplasmosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Cao, J; Chen, Y; Cheng, L; Hu, X; Hua, Q; Liu, S; Lu, D; Tan, F; Tian, Y; Wu, M; Yu, H | 1 |
Li, ZH; Moreno, SN; Ramakrishnan, S; Striepen, B | 1 |
Allocco, JJ; Donald, RG; Liberator, PA; Nare, B | 1 |
3 other study(ies) available for pyrroles and Toxoplasmosis
Article | Year |
---|---|
Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
Topics: Animals; Antiprotozoal Agents; Benzazepines; Cell Survival; Drug Repositioning; Female; Fibroblasts; Foreskin; Humans; Male; Mice; Mice, Inbred BALB C; Parasite Load; Pyrimidines; Pyrroles; Toxoplasma; Toxoplasmosis | 2020 |
Toxoplasma gondii relies on both host and parasite isoprenoids and can be rendered sensitive to atorvastatin.
Topics: Animals; Apicoplasts; Atorvastatin; Diphosphates; Diterpenes; Farnesyltranstransferase; Female; Gene Knockdown Techniques; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Inbred BALB C; Polyisoprenyl Phosphates; Protozoan Proteins; Pyrroles; Sesquiterpenes; Toxoplasma; Toxoplasmosis | 2013 |
Evaluation of a cyclic GMP-dependent protein kinase inhibitor in treatment of murine toxoplasmosis: gamma interferon is required for efficacy.
Topics: Animals; Antiprotozoal Agents; Cyclic GMP-Dependent Protein Kinases; Disease Models, Animal; Enzyme Inhibitors; Female; Immune System; Interferon-gamma; Mice; Mice, Inbred C57BL; Pyridines; Pyrroles; Toxoplasma; Toxoplasmosis; Treatment Outcome | 2002 |